Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Autoradiographic localization of [125I-Tyr0]bradykinin binding sites in brains of Wistar-Kyoto and spontaneously hypertensive rats.

Privitera PJ, Beckstead RM, Yates P, Walgren R.

Cell Mol Neurobiol. 2003 Oct;23(4-5):805-15.

PMID:
14514033
2.
3.

A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats.

Morinelli TA, Webb JG, Jaffa AA, Privitera PJ, Margolius HS.

J Pharmacol Exp Ther. 2001 Jan;296(1):71-6.

PMID:
11123364
4.
5.

Brain kallikrein-kinin system abnormalities in spontaneously hypertensive rats.

Khan IM, Miller DH, Strickland J, Margolius HS, Privitera PJ.

Hypertension. 1995 Apr;25(4 Pt 1):524-30.

PMID:
7721393
6.

Rostral ventrolateral medulla as a site for the central hypertensive action of kinins.

Privitera PJ, Thibodeaux H, Yates P.

Hypertension. 1994 Jan;23(1):52-8.

PMID:
7904256
7.

Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats.

Khan IM, Yamaji I, Miller DH, Margolius HS, Privitera PJ.

J Hypertens. 1993 Oct;11(10):1039-45.

PMID:
8258667
8.

Autoradiographic visualization and characteristics of [125I]bradykinin binding sites in guinea pig brain.

Privitera PJ, Daum PR, Hill DR, Hiley CR.

Brain Res. 1992 Apr 10;577(1):73-9.

PMID:
1325859
9.

Brain kallikrein-kinin system in arterial pressure regulation.

Privitera PJ.

Agents Actions Suppl. 1992;38 ( Pt 3):39-46. Review. No abstract available.

PMID:
1334359
10.

A stereoselective central hypotensive action of atenolol.

Pearson AA, Gaffney TE, Walle T, Privitera PJ.

J Pharmacol Exp Ther. 1989 Sep;250(3):759-63.

PMID:
2778713
11.

Stereochemistry of tissue distribution of racemic propranolol in the dog.

Walle UK, Thibodeaux H, Privitera PJ, Walle T.

Chirality. 1989;1(3):192-6.

PMID:
2642048
12.

C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.

Privitera PJ, Granata AR, Underwood MD, Gaffney TE, Reis DJ.

J Pharmacol Exp Ther. 1988 Aug;246(2):529-33.

PMID:
3404445
13.

Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin.

Thomas GR, Thibodeaux H, Margolius HS, Webb JG, Privitera PJ.

Am J Physiol. 1987 Jul;253(1 Pt 2):R136-41.

PMID:
3605378
14.

Site and mechanism of the centrally mediated hypotensive action of propranolol.

Tackett RL, Webb JG, Privitera PJ.

J Pharmacol Exp Ther. 1985 Oct;235(1):66-70.

PMID:
4045728
15.

Effects of captopril on limiting infarct size in conscious dogs.

Daniell HB, Carson RR, Ballard KD, Thomas GR, Privitera PJ.

J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1043-7.

PMID:
6084760
16.

Orthostatic hypotension with brainstem tumors.

Hsu CY, Hogan EL, Wingfield W Jr, Webb JG, Perot PL Jr, Privitera PJ, Talbert OR, Balentine JD.

Neurology. 1984 Sep;34(9):1137-43.

PMID:
6087207
17.

Cerebrospinal fluid kinins and cardiovascular function. Effects of cerebroventricular melittin.

Thomas GR, Thibodeaux H, Margolius HS, Privitera PJ.

Hypertension. 1984 Mar-Apr;6(2 Pt 2):I46-50.

PMID:
6202636
18.

Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.

Russell MP, Webb JG, Walle T, Daniell HB, Privitera PJ, Gaffney TE.

J Pharmacol Exp Ther. 1983 Aug;226(2):324-9. No abstract available.

PMID:
6875845
19.

Childhood familial and racial differences in physiologic and biochemical factors related to hypertension.

Hohn AR, Riopel DA, Keil JE, Loadholt CB, Margolius HS, Halushka PV, Privitera PJ, Webb JG, Medley ES, Schuman SH, Rubin MI, Pantell RH, Braunstein ML.

Hypertension. 1983 Jan-Feb;5(1):56-70. No abstract available.

PMID:
6336720
20.

Persistence of myocardial failure following removal of chronic volume overload.

Newman WH, Webb JG, Privitera PJ.

Am J Physiol. 1982 Dec;243(6):H876-83.

PMID:
6756171
21.

Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release.

Wilson TW, Loadholt CB, Privitera PJ, Halushka PV.

Hypertension. 1982 Sep-Oct;4(5):634-41. No abstract available.

PMID:
7049918
22.

Nicotinic-like effects and tissue disposition of isopropylamine.

Privitera PJ, Walle T, Gaffney TE.

J Pharmacol Exp Ther. 1982 Jul;222(1):116-21.

PMID:
7086693
23.

Cardiovascular effects of a 4'-methylthio analog of propranolol.

Russel MP, Privitera PJ, Walle T, Peet NP, Halushka PV, Gaffney TE.

J Pharmacol Exp Ther. 1981 Dec;219(3):685-90. No abstract available.

PMID:
6117655
24.

Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.

Tackett RL, Webb JG, Privitera PJ.

Science. 1981 Aug 21;213(4510):911-3.

PMID:
7256285
25.

Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure.

Privitera PJ, Webb JG, Walle T.

Eur J Pharmacol. 1979 Feb 15;54(1-2):51-60. No abstract available.

PMID:
421742
26.

Studies of the interrelationship between plasma norepinephrine, plasma renin activity and acute myocardial infarction in dogs.

Daniell HB, Webb JG, Privitera PJ.

Res Commun Chem Pathol Pharmacol. 1978 May;20(2):289-302.

PMID:
674817
27.

Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.

Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS.

Ann Intern Med. 1977 Sep;87(3):281-6.

PMID:
900671
28.

Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol.

Saelens DA, Walle T, Gaffney TE, Privitera PJ.

Eur J Pharmacol. 1977 Mar 7;42(1):39-46.

PMID:
844488
29.

Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.

Daniell HB, Privitera PJ, Conradi SE, Gaffney TE.

J Pharmacol Exp Ther. 1977 Jan;200(1):155-65.

PMID:
833755
30.
31.

Qualitative metabolic fate of phenoxybenzamine in rat, dog, and man. Use of 15N-labeling.

Knapp DR, Holcombe NH, Krueger SA, Privitera PJ.

Drug Metab Dispos. 1976 Mar-Apr;4(2):164-8.

PMID:
5261
32.

Cardiovascular actions of a new metabolite of propranolol: isopropylamine.

Ishizaki T, Privitera PJ, Walle T, Gaffney TE.

J Pharmacol Exp Ther. 1974 Jun;189(3):626-32. No abstract available.

PMID:
4152314
33.

Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol.

Saelens DA, Walle T, Privitera PJ, Knapp DR, Gaffney T.

J Pharmacol Exp Ther. 1974 Jan;188(1):86-92. No abstract available.

PMID:
4809279
34.

Impaired renin responsiveness with secondary hypoaldosteronism.

Gossain VV, Ferrara EV, Werk EE, Srivastava L, Privitera PJ, Hanenson I.

Arch Intern Med. 1973 Dec;132(6):885-90. No abstract available.

PMID:
4757261
35.

The psychopharmacological effects of a new metabolite of propranolol.

Saelens DA, Walle T, Privitera PJ, Knapp DR, Gaffney T.

Adv Biochem Psychopharmacol. 1973;7:107-12. No abstract available.

PMID:
4742801
36.

Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).

Privitera PJ, Blickenstaff T, Gaffney TE, Mohammed S.

J Pharmacol Exp Ther. 1971 Mar;176(3):655-61. No abstract available.

PMID:
4398744
37.

Hemodynamic effects of phenoxybenzamine in anesthetized dogs.

Fowler NO, Holmes JC, Gaffney TE, Privitera PJ, Grupp G.

J Clin Invest. 1970 Nov;49(11):2036-50.

38.

Potentiation by alpha-methyldopa of pressor responses to angiotensin.

Privitera PJ, Mohammed S.

Proc Soc Exp Biol Med. 1970 Apr;133(4):1358-60. No abstract available.

PMID:
4314860
39.

Effect of methyldopa on plasma renin activity in man.

Mohammed S, Fasola AF, Privitera PJ, Lipicky RJ, Martz BL, Gaffney TE.

Circ Res. 1969 Nov;25(5):543-8. No abstract available.

PMID:
4900604
40.

A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs.

Privitera PJ, Loggie JM, Gaffney TE.

J Pharmacol Exp Ther. 1969 Apr;166(2):293-8. No abstract available.

PMID:
5776987
41.

Effects of hydrocortisone on survival in neonatal beagles given endotoxin.

Loggie JM, Privitera PJ, Sugarman S, Gaffney TE.

Proc Soc Exp Biol Med. 1968 May;128(1):326-9. No abstract available.

PMID:
4872227
42.

Cardiovascular and myocardial metabolic effects of infusions of phenylephrine.

Privitera PJ, Rosenblum I.

J Pharmacol Exp Ther. 1967 May;156(2):325-30. No abstract available.

PMID:
6026262

Supplemental Content

Loading ...
Support Center